Story

Lanxess Reports Wider-Than-Expected Q2 Loss on Restructuring Costs

ENTHMSVIIDZHZH-TWJAKOHI
Aug 7, 20261 min read
Lanxess Reports Wider-Than-Expected Q2 Loss on Restructuring Costs
Text size
Background

German specialty chemicals group Lanxess AG (ETR:LXSG) reported a wider-than-expected net loss for the second quarter, as significant restructuring costs and persistent market headwinds weighed on its bottom line despite a rise in revenue.

By the Numbers

The company announced a net loss of €53 million for the three months ending June 30. This figure represents a larger loss than the €45 million reported in the same period a year earlier and significantly missed the S&P Global Visible Alpha consensus estimate for a €19.9 million loss.

Key financial results from the report include:

  • Revenue: Rose 6.5% year-over-year to €1.56 billion, driven by higher selling prices and increased volumes. This figure was just under the analyst consensus of approximately €1.58 billion.
  • Specialty Additives EBITDA: The division's earnings before exceptional items jumped 33% to €77 million, highlighting it as a key area of strength.

Market Pressures and Segment Performance

Sample IUX Markets – In-articleAd

Lanxess attributed the drag on profitability to several factors, including ongoing restructuring expenses, adverse currency movements, and sustained competitive pressure from Asia. The company also cited continued weak demand from the crucial agrochemicals sector as a significant headwind.

While the Specialty Additives business was a standout performer due to strong demand and improved pricing, other segments lagged. The Consumer Protection and Advanced Intermediates divisions both posted weaker earnings, as benefits from price increases were offset by higher raw material and energy costs, according to the company.

Outlook Reaffirmed

Despite what it described as a "persistently challenging" operating environment, Lanxess reiterated its full-year guidance for fiscal 2026. The company continues to forecast EBITDA before exceptional items in the range of €450 million to €550 million.

Management stated that ongoing cost-cutting and restructuring initiatives are designed to bolster profitability and strategically reduce the group's dependence on the volatile agrochemicals market.

Read next

More on Stocks
Back to latest news

LATEST